Kate Cahill

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. ncbi A preliminary benefit-risk assessment of varenicline in smoking cessation
    Kate Cahill
    Cochrane Tobacco Addiction Group, Department of Primary Health Care, Oxford University, Oxford, UK
    Drug Saf 32:119-35. 2009
  2. ncbi Nicotine receptor partial agonists for smoking cessation
    Kate Cahill
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Cochrane Database Syst Rev 4:CD006103. 2012
  3. ncbi An update on therapeutics for tobacco dependence
    Tim Lancaster
    University of Oxford, Cochrane Tobacco Addiction Review Group, Department of Primary Healthcare, Old Road, Headington, Oxford, OX3 7LF, UK
    Expert Opin Pharmacother 9:15-22. 2008
  4. ncbi Nicotine replacement therapy for smoking cessation
    Lindsay F Stead
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Cochrane Database Syst Rev 11:CD000146. 2012
  5. ncbi Nicotine vaccines for smoking cessation
    Jamie Hartmann-Boyce
    Department of Primary Care Health Sciences, University ofOxford, Oxford, UK
    Cochrane Database Syst Rev 8:CD007072. 2012
  6. ncbi Stage-based interventions for smoking cessation
    Kate Cahill
    Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
    Cochrane Database Syst Rev 11:CD004492. 2010
  7. ncbi Nicotine receptor partial agonists for smoking cessation
    Kate Cahill
    Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
    Cochrane Database Syst Rev 2:CD006103. 2011
  8. ncbi Nicotine receptor partial agonists for smoking cessation
    Kate Cahill
    Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
    Cochrane Database Syst Rev 12:CD006103. 2010

Detail Information

Publications8

  1. ncbi A preliminary benefit-risk assessment of varenicline in smoking cessation
    Kate Cahill
    Cochrane Tobacco Addiction Group, Department of Primary Health Care, Oxford University, Oxford, UK
    Drug Saf 32:119-35. 2009
    ....
  2. ncbi Nicotine receptor partial agonists for smoking cessation
    Kate Cahill
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Cochrane Database Syst Rev 4:CD006103. 2012
    ....
  3. ncbi An update on therapeutics for tobacco dependence
    Tim Lancaster
    University of Oxford, Cochrane Tobacco Addiction Review Group, Department of Primary Healthcare, Old Road, Headington, Oxford, OX3 7LF, UK
    Expert Opin Pharmacother 9:15-22. 2008
    ..Recent evidence suggests that the nicotine-receptor partial agonist varenicline is at least as effective as nicotine replacement therapy and antidepressants...
  4. ncbi Nicotine replacement therapy for smoking cessation
    Lindsay F Stead
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Cochrane Database Syst Rev 11:CD000146. 2012
    ....
  5. ncbi Nicotine vaccines for smoking cessation
    Jamie Hartmann-Boyce
    Department of Primary Care Health Sciences, University ofOxford, Oxford, UK
    Cochrane Database Syst Rev 8:CD007072. 2012
    ..By reducing the amount of nicotine that reaches the brain when a person smokes a cigarette, nicotine vaccines may help people to stop smoking or to prevent recent quitters from relapsing...
  6. ncbi Stage-based interventions for smoking cessation
    Kate Cahill
    Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
    Cochrane Database Syst Rev 11:CD004492. 2010
    ..People in the preparation and action stages of quitting would require different types of support from those in precontemplation or contemplation...
  7. ncbi Nicotine receptor partial agonists for smoking cessation
    Kate Cahill
    Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
    Cochrane Database Syst Rev 2:CD006103. 2011
    ..The first trial reports of varenicline were released in 2006, and further trials have now been published or are currently underway...
  8. ncbi Nicotine receptor partial agonists for smoking cessation
    Kate Cahill
    Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
    Cochrane Database Syst Rev 12:CD006103. 2010
    ..The first trial reports of varenicline were released in 2006, and further trials have now been published or are currently underway...